Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.

他のバージョン（1件）を表示する

OBJECTIVES: The use of clinical staging in the fatal neurodegenerative disease amyotrophic lateral sclerosis would have value in optimising future therapeutic trials. We aimed to use previous clinical trial data to determine the length of time patients spend in each of four proposed stages, its rang...

書誌詳細
主要な著者:	Balendra, R, Jones, A, Jivraj, N, Steen, I, Young, C, Shaw, P, Turner, M, Leigh, P, Al-Chalabi, A
フォーマット:	Journal article
言語:	English
出版事項:	2015

類似資料

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
著者:: Balendra, R, 等
出版事項: (2015)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
著者:: Jones, A, 等
出版事項: (2014)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
著者:: Balendra, R, 等
出版事項: (2014)

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
著者:: Jones, A, 等
出版事項: (2013)

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
著者:: Balendra, R, 等
出版事項: (2013)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2002)

A proposed staging system for amyotrophic lateral sclerosis.
著者:: Roche, J, 等
出版事項: (2012)

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2007)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
著者:: Al-Chalabi, A, 等
出版事項: (2003)

Biomarkers in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2009)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
著者:: Rutter-Locher, Z, 等
出版事項: (2016)

Amyotrophic lateral sclerosis
著者:: Leigh P Nigel, 等
出版事項: (2009-02-01)

Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
著者:: Xueping Chen, 等
出版事項: (2018-06-01)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
著者:: Turner, M, 等
出版事項: (2020)

Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: Observational study
著者:: Garcia-Gancedo, L, 等
出版事項: (2019)

Evolution of white matter damage in amyotrophic lateral sclerosis
著者:: Gabel, M, 等
出版事項: (2020)

Amyotrophic lateral sclerosis and cerebellum
著者:: Renata Kabiljo, 等
出版事項: (2022-07-01)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
著者:: Turner, M, 等
出版事項: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
著者:: Turner, M, 等
出版事項: (2012)

Quantifying disease progression in amyotrophic lateral sclerosis.
著者:: Simon, N, 等
出版事項: (2014)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
著者:: Corcia P, 等
出版事項: (2012-08-01)

Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.
著者:: Johnston, C, 等
出版事項: (2006)

Clinical Controversies in Amyotrophic Lateral Sclerosis
著者:: Ruaridh Cameron Smail,, 等
出版事項: (2020-07-01)

Clinical psychology and amyotrophic lateral sclerosis
著者:: Francesco Pagnini, 等
出版事項: (2010-07-01)

Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study
著者:: Garcia-Gancedo, Luis, 等
出版事項: (2019-12-01)

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis
著者:: Henderson, R, 等
出版事項: (2018)

Evolution of white matter damage in amyotrophic lateral sclerosis
著者:: Matt C. Gabel, 等
出版事項: (2020-05-01)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
著者:: Abrahams, S, 等
出版事項: (1997)

Amyotrophic lateral sclerosis.
著者:: Kiernan, M, 等
出版事項: (2011)

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
著者:: Scott, K, 等
出版事項: (2009)

Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis
著者:: Yildiz, O, 等
出版事項: (2025)

The reunification of amyotrophic lateral sclerosis
著者:: Turner, M
出版事項: (2018)

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2011)

Neuroimaging in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2012)

The sex ratio in amyotrophic lateral sclerosis: A population based study.
著者:: Manjaly, Z, 等
出版事項: (2010)

Clinical neurorestorative progress in amyotrophic lateral sclerosis
著者:: Chen L, 等
出版事項: (2015-08-01)

Progress in clinical diagnosis of amyotrophic lateral sclerosis
著者:: Qiong YANG, 等
出版事項: (2012-06-01)

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
著者:: Kelly, M, 等
出版事項: (2020)

Amyotrophic lateral sclerosis: Clinical heterogeneity and approaches to classification
著者:: I. S. Bakulin, 等
出版事項: (2017-11-01)

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.
著者:: Fang, F, 等
出版事項: (2013)